Practice parameter Therapies for essential tremor : Report of the quality standards subcommittee of the american academy of neurology von ZESIEWICZ, T. A, ELBLE, R, LOUIS, E. D, HAUSER, R. A, SULLIVAN, K. L, DEWEY, R. B, ONDO, W. G, GRONSETH, G. S, WEINER, W. J

Volltext

Ropinirole for restless legs syndrome: A placebo-controlled crossover trial von ADLER, C. H, HAUSER, R. A, SETHI, K, CAVINESS, J. N, MARLOR, L, ANDERSON, W. M, HENTZ, J. G

Volltext

Quantitative description of loss of clinical benefit following withdrawal of levodopa-carbidopa and bromocriptine in early Parkinson's disease von Hauser, Robert A., Holford, Nicholas H.G.

Volltext

Dyskinesia matters von Cenci, M. Angela, Riggare, Sara, Pahwa, Rajesh, Eidelberg, David, Hauser, Robert A.

Volltext

Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey von Hermanowicz, Neal, Jones, Sarah A, Hauser, Robert A

Volltext

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlle... von LeWitt, Peter A, Hauser, Robert A, Pahwa, Rajesh, Isaacson, Stuart H, Fernandez, Hubert H, Lew, Mark, Saint-Hilaire, Marie, Pourcher, Emmanuelle, Lopez-Manzanares, Lydia, Waters, Cheryl, Rudzínska, Monika, Sedkov, Alexander, Batycky, Richard, Oh, Charles

Volltext

Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease von Hauser, Robert A., Olanow, C. Warren, Dzyngel, Bruce, Bilbault, Thierry, Shill, Holly, Isaacson, Stuart, Dubow, Jordan, Agro, Albert

Volltext

Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial von SCHAPIRA, A. H. V, BARONE, P, HAUSER, R. A, MIZUNO, Y, RASCOL, O, BUSSE, M, SALIN, L, JUHEL, N, POEWE, W

Volltext

Reply to: Letter to Editor by Chaudhuri, Jenner, Antonini von Hauser, RA, Eidelberg, D, Pahwa, R, Riggare, S, Cenci, MA

Volltext

Dyskinesia Matters: But Not as Much as It Used to Reply von Hauser, RA, Eidelberg, D, Pahwa, R, Riggare, S, Cenci, MA

Volltext

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations von Hauser, Robert A., Shulman, Lisa M., Trugman, Joel M., Roberts, John W., Mori, Akihisa, Ballerini, Rocco, Sussman, Neil M.

Volltext

Reply to: Letter to Editor by Chaudhuri, Jenner, Antonini von Hauser, Robert A., Eidelberg, David, Pahwa, Rajesh, Riggare, Sara, Cenci, M. Angela

Volltext

Long-term evaluation of deep brain stimulation of the thalamus von PAHWA, Rajesh, LYONS, Kelly E, JANKOVIC, Joseph, WILKINSON, Steven B, SIMPSON, Richard K, ONDO, William G, TARSY, Daniel, NORREGAARD, Thorkild, HUBBLE, Jean P, SMITH, Donald A, HAUSER, Robert A

Volltext

Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease von Hauser, Robert A., Ellenbogen, Aaron L., Metman, Leo Verhagen, Hsu, Ann, O'Connell, Martin J., Modi, Nishit B., Yao, Hsuan-Ming, Kell, Sherron H., Gupta, Suneel K.

Volltext

Parkinson's disease home diary: Further validation and implications for clinical trials von Hauser, Robert A., Deckers, Frieda, Lehert, Philippe

Volltext

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study von Whone, Alan L., Watts, Ray L., Stoessl, A. Jon, Davis, Margaret, Reske, Sven, Nahmias, Claude, Lang, Anthony E., Rascol, Olivier, Ribeiro, Maria J., Remy, Philippe, Poewe, Werner H., Hauser, Robert A., Brooks, David J.

Volltext

Randomized trial of the adenosine A(2A) receptor antagonist istradefylline in advanced PD von Hauser, Robert A, Hubble, Jean P, Truong, Daniel D

Volltext

Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease von Hauser, Robert A, Ellenbogen, Aaron, Khanna, Sarita, Gupta, Suneel, Modi, Nishit B

Volltext

AbobotulinumtoxinA time to retreatment across indications von Gracies, Jean-Michel, Delgado, Mauricio R., Hauser, Robert A., Grimes, David A., Picaut, Philippe, Mann, Amandeep, Om, Savary

Volltext

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double-blind, placebo-controlled study von Truong, Daniel, Duane, Drake D., Jankovic, Joseph, Singer, Carlos, Seeberger, Lauren C., Comella, Cynthia L., Lew, Mark F., Rodnitzky, Robert L., Danisi, Fabio O., Sutton, James P., Charles, P. David, Hauser, Robert A., Sheean, Geoffrey L.

Volltext